Subscribe

Archive | Cannabis Science Inc

Issue No.15 Sativa Magazine – April 2014

sativamagapril2014

Cannabis Investors and Marijuana Stocks Welcome to the Cannabis investment special. With listings of stocks for companies serving areas of the Cannabis market and lists of investors with money to burn. here is the launching pad for your Cannabis business idea. Work hard!

Cannabis Science (CBIS) Moves Forward with Critical Support of Landmark Federal Cannabis Legislative Initiative

CannabisScience

COLORADO SPRINGS, Colo., Dec. 2, 2013 /PRNewswire/ — (NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development, is a key leader in the private sector challenge to end the restrictions on cannabis drug development and research in the U.S.  “The Cannabinoid Scientific Research and Development Act,” which will be submitted […]

Cannabis Science Working With cannabis caucus in the U.S. House of Representatives in the Fight to Level the Playing Field for Cannabis Drug Research and Development

CannabisScience

COLORADO SPRINGS, Colo., Nov. 25, 2013 /PRNewswire/ — (NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development, is working with the the cannabis caucus in the U.S. House of Representatives to initiate substantial changes in 2014 in the way cannabis research and drug development can be done in this country. Working […]

Scammers Target Cannabis Stocks

RiskAppetiteMunchies

Caught a segment on CNBC today about FINRA warning investors about the stocks within the Cannabis Industry. The following letter was issued by their Frauds & Scams Investor Alert: Marijuana Stock Scams With medical marijuana legal in almost 20 states, and recreational use of the drug recently legalized in two states, the cannabis business has been […]

Cannabis Science announces Therapeutic Discovery Program initiated in the Netherlands, executed along U.S. guidelines for regulatory submission

CannabisScience

AMSTERDAM, April 26, 2013 /PRNewswire/ — Cannabis Science, Inc. (CBIS) announced today the initiation of preclinical development characterization of CS-TATI-I following the execution of contractual retention of vendor labs located in the Amsterdam Life Science Cluster. Under the direction of Richard Ogden, PhD, Chief Scientific Officer, and Christopher Meenan, MBA, MS, Executive Vice President of Product […]

Cannabis Science Announces Screening of ‘American Drug War II,’ Film by Kevin Booth, on Thursday, April 18

gw_pharmaceuticals

COLORADO SPRINGS, Colo., April 16, 2013 /PRNewswire/ — Cannabis Science, Inc. (CBIS) is pleased to announce Sacred Cow Production presents American Drug War II, a film by Kevin Booth, for national release on June 6, 2013, as Dr. Robert Melamede, President and CEO of Cannabis Science, appears in the film and played a production role. […]

Cannabis Science, Inc. Appoints Michael McGrath, MD, PhD, Professor, Departments of Laboratory Medicine, Pathology, and Medicine, UCSF, and Co-Founder of Biotechs Pathologica LLC and Neuraltus Pharmaceuticals, to the Company’s Scientific Advisory Board

CannabisScience

COLORADO SPRINGS, Colo., March 27, 2013 /PRNewswire/ — Cannabis Science, Inc. (NASDAQ OTC: CBIS) Cannabis Science announced today the appointment of Dr. Michael McGrath MD, PhD, Professor, Departments of Laboratory Medicine, Pathology, and Medicine at The University of California San Francisco (UCSF) to the Company’s Scientific Advisory Board. He has authored over 100 scientific articles […]

Cannabis Science Appoints Richard Ogden, PhD, Former Director of Scientific Affairs At Pfizer, as Chief Scientific Officer

CannabisScience

COLORADO SPRINGS, Colo., Feb. 27, 2013 /PRNewswire/ — Cannabis Science, Inc. (NASDAQ OTC: CBIS) is pleased to announce the appointment of Richard Ogden, Ph.D., Former Director of Scientific Affairs, HIV, Pfizer, as Chief Scientific Officer of Cannabis Science.  Dr. Ogden’s knowledge, experience and success in the discovery, development and commercialization of new therapeutics for HIV […]

XCHC Signs Historic Agreement with Maliseet Nation to Allow Medical Cannabis Hospitals

CannabisScience

DALLAS, Feb. 13, 2013 /PRNewswire/ — The X-Change Corporation (NASDAQ OTC: XCHC) (X-Change Corp. or the Company), a U.S. boutique company whose niche is cannabis and hemp based extracts and products that target medical cannabis, cosmeceutical, nutraceutical, and social usage solutions through multiple Phytiva Brand product lines and solutions, is proud to announce it has entered […]

Cannabis Science Appoints Harold C. Smith, Ph.D to Scientific Advisory Board

CannabisScience

COLORADO SPRINGS, Colo., Feb. 12, 2013 /PRNewswire/ — Cannabis Science, Inc. (NASDAQ OTC: CBIS) has appointed Harold C. Smith, Ph.D., Professor in Biochemistry, Biophysics, and Oncology with secondary appointments as Professor in the Department of Genetics and Pathology and a Member of the Center for RNA Biology at the University of Rochester, School of Dentistry and […]